{
    "nctId": "NCT02995772",
    "briefTitle": "Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients",
    "officialTitle": "Preoperative Neoadjuvant Hormonal Therapy and Neoadjuvant Chemotherapy for Stage IIIB and IV Breast Cancer Patients in Dharmais National Cancer Center Hospital, Indonesia",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 122,
    "primaryOutcomeMeasure": "Overall survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* IIIB/C and IV stage of breast cancer\n* received neoadjuvant hormonal therapy or neoadjuvant chemotherapy\n* had first and second biopsy (surgery) within 6 months\n\nExclusion Criteria:\n\n* had mastectomy before treatment\n* pregnant\n* disagree to enter the study\n* had been given hormonal therapy or chemotherapy before study\n* had contra-indication of SOB for pre-menopausal patients",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}